TY - JOUR
T1 - Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle
AU - Desjardins, Paul
AU - Rama Rao, K. V.
AU - Michalak, Adrianna
AU - Rose, Christopher
AU - Butterworth, Roger F.
N1 - Funding Information:
The authors are grateful to Dominique D. Roy for her help with the preparation of this manuscript. The studies described were funded by The Medical Research Council of Canada.
PY - 1999
Y1 - 1999
N2 - The effects of chronic liver insufficiency resulting from end-to-side portacaval anastomosis (PCA) on glutamine synthetase (GS) activities, protein and gene expression were studied in brain, liver and skeletal muscle of male adult rats. Four weeks following PCA, activities of GS in cerebral cortex and cerebellum were reduced by 32% and 37% (p<0.05) respectively whereas GS activities in muscle were increased by 52% (p<0.05). GS activities in liver were decreased by up to 90% (p<0.01), a finding which undoubtedly reflects the loss of GS-rich perivenous hepatocytes following portal-systemic shunting. Immunoblotting techniques revealed no change in GS protein content of brain regions or muscle but a significant loss in liver of PCA rats. GS mRNA determined by semiquantitative RT-PCR was also significantly decreased in the livers of PCA rats compared to sham-operated controls. These findings demonstrate that PCA results in a loss of GS gene expression in the liver and that brain does not show a compensatory induction of enzyme activity, rendering it particularly sensitive to increases in ammonia in chronic liver failure. The finding of a post-translational increase of GS in muscle following portacaval shunting suggests that, in chronic liver failure, muscle becomes the major organ responsible for the removal of excess blood-borne ammonia.
AB - The effects of chronic liver insufficiency resulting from end-to-side portacaval anastomosis (PCA) on glutamine synthetase (GS) activities, protein and gene expression were studied in brain, liver and skeletal muscle of male adult rats. Four weeks following PCA, activities of GS in cerebral cortex and cerebellum were reduced by 32% and 37% (p<0.05) respectively whereas GS activities in muscle were increased by 52% (p<0.05). GS activities in liver were decreased by up to 90% (p<0.01), a finding which undoubtedly reflects the loss of GS-rich perivenous hepatocytes following portal-systemic shunting. Immunoblotting techniques revealed no change in GS protein content of brain regions or muscle but a significant loss in liver of PCA rats. GS mRNA determined by semiquantitative RT-PCR was also significantly decreased in the livers of PCA rats compared to sham-operated controls. These findings demonstrate that PCA results in a loss of GS gene expression in the liver and that brain does not show a compensatory induction of enzyme activity, rendering it particularly sensitive to increases in ammonia in chronic liver failure. The finding of a post-translational increase of GS in muscle following portacaval shunting suggests that, in chronic liver failure, muscle becomes the major organ responsible for the removal of excess blood-borne ammonia.
KW - Ammonia
KW - Gene expression
KW - Glutamine synthetase
KW - Hepatic encephalopathy
KW - Liver
KW - Portacaval anastomosis
KW - Skeletal muscle
UR - http://www.scopus.com/inward/record.url?scp=0342314620&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0342314620&partnerID=8YFLogxK
U2 - 10.1023/A:1020741226752
DO - 10.1023/A:1020741226752
M3 - Article
C2 - 10850554
AN - SCOPUS:0342314620
SN - 0885-7490
VL - 14
SP - 273
EP - 280
JO - Metabolic Brain Disease
JF - Metabolic Brain Disease
IS - 4
ER -